An increasing number of ACE inhibitors have become available in recent years. Because
these agents are all similar. careful scrutiny is required in order to determine specific …

Background: Current hypertension guidelines differ in their recommendations for first-line
antihypertensive therapy. Objective: To evaluate the cost effectiveness of ACE inhibitor …

ACE inhibitors have been available by prescription since the marketing of captopril in the
early 1980s. Since that time, six additional ACE inhibitors have been marketed, four of which …

The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important
one. The available evidence suggests that in chronic heart failure as well as in chronic …

Events began in 1981 with the introduction of captopril. Initially approved for treatment of
severe refractory hypertension, it soon became accepted for all kinds of hypertension as well …

The orally active angiotensin-converting inhibitors (ACE inhibitors) such as captopril and
enalapril represent a significant therapeutic advance in the treatment of hypertension and …

Medicines that affect the renin-angiotensin-aldosterone system are effective in several
diseases. Angiotensin-converting enzyme (ACE) inhibitors block the conversion of …

Objectives: Identify the mechanism of action of ACE inhibitors. Summarize monitoring/follow-
up for patients initiated on ACE inhibitor therapy. Review the dosing parameters adjusting or …

Preview ACE inhibitors are apparently both safe and effective for antihypertensive therapy
and do not have a negative impact on quality of life. Compliance is enhanced by ease of …

Angiotensin converting enzyme inhibitors are established treatment for hypertension and
heart failure. There are well documented differences between ACE inhibitors both in …